FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
7/25/2017
0:00
NaN:NaN:NaN
FDA medical oncologists discuss the FDA approvals of brigatinib and ceritinib for ALK-positive non-small cell lung cancer.
Released July 25, 2017
More episodes from "FDA Drug Information Updates"
Don't miss an episode of “FDA Drug Information Updates” and subscribe to it in the GetPodcast app.